Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rezolute, Inc.

3.10
-0.0400-1.27%
Volume:451.55K
Turnover:1.42M
Market Cap:187.66M
PE:-2.64
High:3.32
Open:3.15
Low:3.03
Close:3.14
Loading ...

Rezolute Says it Gets Breakthrough Therapy Designation From US FDA for Ersodetug to Treat Hypoglycemia

MT Newswires Live
·
07 Jan

Rezolute receives BTD from FDA for ersodetug in treatment of hypoglycemia

TIPRANKS
·
07 Jan

BRIEF-Rezolute Receives Breakthrough Therapy Designation From FDA For Ersodetug In The Treatment Of Hypoglycemia Due To Congenital Hyperinsulinism

Reuters
·
07 Jan

Rezolute Inc: Topline Sunrize Data Expected Second Half of This Year

THOMSON REUTERS
·
07 Jan

Rezolute Receives Breakthrough Therapy Designation From FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

THOMSON REUTERS
·
07 Jan

3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying

Zacks
·
24 Dec 2024

Rezolute reports inducement award under Nasdaq listing rule

TIPRANKS
·
05 Dec 2024

Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Dec 2024

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires Live
·
04 Dec 2024

Rezolute Gets FDA Orphan Drug Designation for Ersodetug in Tumor Hyperinsulinism-Related Hypoglycemia

MT Newswires Live
·
03 Dec 2024

Rezolute Receives Orphan-Drug Designation from FDA for Low Blood Sugar Treatment

Dow Jones
·
03 Dec 2024

Rezolute announces U.S. FDA granted ODD to ersodetug

TIPRANKS
·
03 Dec 2024

FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (Rz358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

THOMSON REUTERS
·
03 Dec 2024

Rezolute, Inc. Advances Late-Stage Trials for Rare Disease Therapies

TIPRANKS
·
26 Nov 2024

Rezolute granted FDA orphan designation for treatment of hypoglycemia

TIPRANKS
·
21 Nov 2024

We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully

Simply Wall St.
·
13 Nov 2024

Rezolute Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Nov 2024

Rezolute Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Rezolute Q1 EPS $(0.22) Beats $(0.33) Estimate

Benzinga
·
08 Nov 2024

BRIEF-Rezolute Q1 EPS USD -0.22

Reuters
·
08 Nov 2024